Literature DB >> 6864073

Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease.

J C Hoefs.   

Abstract

UNLABELLED: The ascitic fluid and serum concentrations of albumin and globulin were measured simultaneously with transhepatic portal pressure determination in 56 patients with chronic liver disease to determine whether (1) portal pressure correlated with (S-Asc)A and (2) the majority of variation in ascitic fluid protein concentration between patients was related to fluid balance from serum to ascites. The mean ascitic fluid albumin concentration was 1.04 +/- 0.73 gm/dl; globulin concentration 1.31 +/- 0.80 gm/dl; and ascitic fluid total protein concentration 2.35 +/- 1.49 gm/dl. The mean serum albumin concentration was 2.58 +/- .57 gm/dl; globulin concentration 3.91 +/- .86 gm/dl; and total protein concentration 6.49 +/- 1.30 gm/dl. The (S-Asc)A was 1.54 +/- .45 gm/dl. The mean PPIVC was 14.5 +/- 4.3 mm Hg. The (S-Asc)A correlated directly with PPIVC (r = 0.73; p less than 0.0001). The ascitic fluid protein correlated with three variables that did not correlate with each other: serum albumin (r = 0.67; p less than 0.0001), serum globulin (r = 0.44; p less than 0.001), and PPIVC (r = -0.48; p less than 0.0005). The sum of the squared correlation coefficients with these latter uncorrelated variables equaled 0.87 and partial correlation coefficient analyses demonstrated an increase in the correlation of the ascitic fluid protein with the serum albumin concentration when corrected for serum globulin and (S-Asc)A (r = 0.97; p less than 0.0001) or PPIVC (r = 0.90; p less than 0.0001). Thus most of the variation in ascitic fluid protein between patients in this study could be related to serum protein concentrations and PPIVC or (S-Asc)A. Furthermore, multivariate discriminant analysis of patients with an ascitic fluid protein less than or equal to 2.5 vs. greater than 2.5 gm/dl indicated that the majority of differences between the two groups could be attributed to differences in serum albumin and serum globulin in combination with the (S-Asc)A (canonical correlation = 0.808) or PPIVC (canonical correlation = 0.806). These factors could correctly identify the low or high ascitic fluid protein groups in 96% and 93% of patients, respectively. IN
CONCLUSION: (1) the (S-Asc)A is associated with the degree of portal pressure elevation and (2) the majority of variation in ascitic fluid protein concentration between patients with chronic liver disease is associated with differences in portal pressure and serum protein concentrations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6864073

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  25 in total

1.  Is the pleural fluid transudate or exudate? A revisit of the diagnostic criteria.

Authors:  J Joseph; P Badrinath; G S Basran; S A Sahn
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

2.  Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures.

Authors:  Suma L Sangisetty; Thomas J Miner
Journal:  World J Gastrointest Surg       Date:  2012-04-27

3.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 4.  Biochemical Analysis of Pleural Fluid and Ascites.

Authors:  Sa Paul Chubb; Robin A Williams
Journal:  Clin Biochem Rev       Date:  2018-05

5.  ACCURACY OF SERUM - ASCITES ALBUMIN GRADIENT IN THE AETIOLOGICAL DIAGNOSIS OF ASCITES.

Authors:  A K Seth; R Rangarao; R Pakhetra; V Baskaran; Pvs Rana; S Rajamani
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 6.  Myxedema ascites: case report and literature review.

Authors:  Jeong-Seon Ji; Hiun-Suk Chae; Young-Seok Cho; Hyung-Keun Kim; Sung-Soo Kim; Chang-Wook Kim; Chang-Don Lee; Bo-In Lee; Hwang Choi; Kang-Moon Lee; Hye-Kyung Lee; Kyu-Yong Choi
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

7.  Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection.

Authors:  J Such; D J Hillebrand; C Guarner; L Berk; P Zapater; J Westengard; C Peralta; G Soriano; J Pappas; B A Runyon
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

8.  Prevention of the Paracentesis-Induced Circulatory Dysfunction (PICD) in Cirrhosis: Is the SPA Treatment Worthwhile?

Authors:  John Carl Hoefs
Journal:  Dig Dis Sci       Date:  2016-08-23       Impact factor: 3.199

9.  Serum-ascites albumin gradients in nonalcoholic liver disease.

Authors:  M A Kajani; Y K Yoo; J A Alexander; J S Gavaler; R E Stauber; V J Dindzans; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

10.  Factors that determine refractoriness of ascites to conventional therapy.

Authors:  S Amra; R Elie; I Kronborg
Journal:  CMAJ       Date:  1986-09-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.